Table 6 Mono-factor analysis of 5-year postoperative survival rate of patients with different pathological type.
5-year postoperative survival rate of Squamous cell carcinomas | P | 5-year postoperative survival rate of Adenocarcinoma | P | |
|---|---|---|---|---|
Age | ||||
≤60y | 68.8% | 0.584 | 70.6% | 0.150 |
>60y | 61.1% | 47.8% | ||
Gender | ||||
Male | 66.7% | 0.626 | 60.0% | 0.680 |
Female | 50.0% | 53.3% | ||
Tumor differentiation grade | ||||
Poorly differentiated | 60.0% | 0.091 | 46.2% | 0.314 |
Middle-, high-differentiated | 72.0% | 63.0% | ||
Diameter of tumor | ||||
≤4cm | 66.7% | 0.778 | 61.3% | 0.368 |
>4cm | 65.4% | 44.4% | ||
pTNM stage | ||||
I stage | 75.0% | 0.001 | 68.8% | 0.342 |
II stage | 82.4% | 62.5% | ||
III stage | 11.1% | 43.8% | ||
Smoking status | ||||
Yes | 66.7% | 0.851 | 56.3% | 0.896 |
No | 63.6% | 58.3% | ||
The plasma level of HIF-1α | ||||
≤297.70 pg/ml | 78.6% | 0.034 | 47.1% | 0.251 |
>297.70 pg/ml | 50.0% | 65.2% | ||
